Satellos Bioscience Inc
(MSCLF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Cash Flows From Operating Activities | |
| Net Income | -1,040 |
| Depreciation Amortization | 110 |
| Other Working Capital | -40 |
| Other Operating Activity | -980 |
| Operating Cash Flow | $-1,950 |
| Cash Flows From Investing Activities | |
| PPE Investments | 330 |
| Other Investing Activity | 190 |
| Investing Cash Flow | $520 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 1,050 |
| Financing Cash Flow | $1,050 |
| Beginning Cash Position | 630 |
| End Cash Position | 250 |
| Net Cash Flow | $-380 |
| Free Cash Flow | |
| Operating Cash Flow | -1,950 |
| Free Cash Flow | -1,950 |